StonvexLoading…
StonvexStonvexStonvexCore line items from HUMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $495.00K | $2.04M | $1.57M | $818.00K |
Operating Income | $-28.93M | $-108.14M | $-77.30M | $-52.91M |
Net Income | $-17.62M | $-40.83M | $-16.03M | $-37.66M |
EPS (Diluted) | $-0.09 | $-0.26 | $-0.11 | $0.01 |
Total Assets | $110.56M | $116.37M | $91.51M | $138.79M |
Total Liabilities | $98.93M | $113.26M | $96.26M | $134.74M |
Cash & Equivalents | $48.54M | $50.50M | $19.49M | $38.03M |
Free Cash Flow OCF − CapEx | $-25.28M | $-105.93M | $-79.76M | $-55.81M |
Shares Outstanding | 222.02M | 193.00M | 158.84M | 156.34M |